Relsys releases new version of Argus

Relsys International has released the Argus Safety Suite 5.0, an update to the most widely-used Drug Safety & Risk Management system in the  world, according to the firm.

It includes Argus Perceptive 5.0 with greater data accuracy, ensuring  that medical reviewers get advanced notice of signals, aiding earlier  risk identification. While adhering to the structured signal management  approach, the system allows pharmaceutical companies to ensure that  their surveillance teams follow the signal and risk management process  according to company-defined processes within an integrated environment.  Bruce Palsulich, chief innovation and strategy officer said:  "increasing regulatory scrutiny and greater physician/consumer awareness  have led directly to a record number of adverse events reported to  regulators. In fact, in the first quarter of 2008, the FDA received a  record number of adverse event reports, 82% of which originated from  manufacturers. Pharma companies are struggling to meet this burden and  are increasingly looking to commercial drug safety databases to help  manage their regulatory requirements. I believe this is exactly why more  than one out of every three of the top 100 pharma have selected Argus  Safety from Relsys to manage their pharmacovigilance obligations."